Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 43 Projects
Project # Contact PI Funding Organization Fiscal Year
Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease
ADDF-25 Orr, Miranda Alzheimer's Drug Discovery Foundation 2020
5th Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Rasagiline Rescue in Alzheimer’s Disease Clinical Trial (R2 Trial) – Biomarker add-on funding
GC-201908-2019444 Cummings, Jeffrey Alzheimer's Drug Discovery Foundation 2019
Repurposing lenalidomide for early Alzheimer's treatment
GC-2013717 Sabbagh, Marwan Alzheimer's Drug Discovery Foundation 2018
Effect of early supplementation with high dose DHA on cognitive outcomes in APOE4 carriers: "PreventE4 Trial"
GC-201711-2014197 Yassine, Hussein Alzheimer's Drug Discovery Foundation 2018
Inflammatory Markers for Early Detection & Subtyping of Neurodegenerative & Mood Disorders
GC-201712-2014401 Upton, Meredith Alzheimer's Drug Discovery Foundation 2018
A pilot pharmacodynamic study of Anti-SEMA4D Antibody (VX15) in early Alzheimer’s disease
GC-201801-2014580 Siemers, Eric Alzheimer's Drug Discovery Foundation 2018
Phase 2 Enabling Toxicology Studies of MW151, A Selective Small Molecule Suppressor of Neuroinflammation for Alzheimer’s Disease
GC-201801-2014589 Van Eldik, Linda Alzheimer's Drug Discovery Foundation 2018
SHINE (Study Synaptic Health and Improvement of Neurological Function with Elayta): A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
GC-201810-2017524 Catalano, Susan Alzheimer's Drug Discovery Foundation 2018
Manufacture and testing of GMP grade senicapoc for a Phase 2 clinical trial repurposing for Prodromal & mild AD.
GC-2013352 Olichney, John Alzheimer's Drug Discovery Foundation 2017
Phase 1 Studies and preparation of clinical phase 2 IND of MW150 : Novel Stress Kinase Inhibitor Candidate
GC-2013554 WINDISCH, MANFRED Alzheimer's Drug Discovery Foundation 2017